Document is current

Any future updates will be listed below

NSCLC: Immuntherapie in der Erstlinie verlängert Überleben

Crossref DOI link: https://doi.org/10.1007/s15015-018-3944-8

Published Online: 2018-04-06

Published Print: 2018-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark